1 |
Ahn HS. Introduction to Evidence-based Medicine. Journal of Korean Society of Quality Assurance in Health Care. 2005;12(2):9-16.
|
2 |
Lim YC. A Critical Contemplation on 'Personalized Medicine' of Modern Medicine. The Korean Association for Philosophy of Medicine. 2012; 13:135-162.
|
3 |
Hong KW, Oh B. Overview of personalized medicine in the disease genomic era. BMB Rep. 2010;43(10):643648.
|
4 |
Lee SW, Lee KB, Kang JW, Choi JH, Oh JH. Trends in Personalized Medicine Research, Communications of the Korean Institute of Information Scientists and Engineer. 2011;29(4): 19-25.
|
5 |
Zhou SF, Di YM, Chan E, Du YM, Chow VD, Xue CC, et al. Clinical Pharmacogenetics and Potential Application in Personalized Medicine. Curr Drug Metab. 2008;9(8):738-84.
DOI
ScienceOn
|
6 |
Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med. 2010; 363(4):301-4.
DOI
ScienceOn
|
7 |
Ng PC, Murray SS, Levy S, Venter JC. An agenda for personalized medicine. Nature. 2009; 461(7265):724-6.
DOI
ScienceOn
|
8 |
Fung EY, Smyth DJ, Howson JM, Cooper JD, Walker NM, Stevens H, et al. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun. 2009;10(2): 188-91.
DOI
ScienceOn
|
9 |
Dai J, Fang J, Sun S, Chen Q, Cao H, Zheng N, et al. ZHENG-Omics Application in ZHENG Classification and Treatment: Chinese Personalized Medicine. Evid Based Complement Alternat Med. 2013;2013:235969.
|
10 |
Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA. 1992; 268(17):2420-5.
DOI
ScienceOn
|
11 |
Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ. 1996; 312(7023):71-2.
DOI
ScienceOn
|
12 |
Rosenberg W, Donald A. Evidence based medicine: an approach to clinical problem-solving. BMJ. 1995;310(6987):1122-6.
DOI
ScienceOn
|
13 |
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661-78.
DOI
ScienceOn
|
14 |
Gispen WH, Adan RAH. Preface. Eur J Pharmacol. 2000;410(2-3):105.
DOI
|
15 |
Shin JG, Cha IJ. Pharmacogenetics: A Principle for the Personalized Pharmacotherapy. Inje Medical Journal. 2002;23(2):71-83.
|
16 |
Yan Q. Pharmacogenomics in Drug Discovery and Development : From Bench to Bedside. Clifton:Methods Mol Biol. 2008;448:5-7.
|
17 |
Zhang A, Sun H, Wang P, Han Y, Wang X. Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach. Complement Ther Med. 2012;20(1-2): 93-9.
DOI
|
18 |
Wang X, Sun H, Zhang A, Sun W, Wang P, Wang Z. Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine. J Pharm Biomed Anal. 2011;55(5):859-68.
DOI
ScienceOn
|
19 |
Kim WH. Hanuihak Wonron. Seoul:Seongbosa. 2001:32-34.
|
20 |
Lesko LJ. Personalized medicine: elusive dream or imminent reality?. Clin Pharmacol Ther. 2007;81(6):807-16.
DOI
|
21 |
Schleidgen S, Klingler C, Bertram T, Rogowski WH, Marckmann G. What is personalized medicine: sharpening a vague term based on a systematic literature review. BMC Med Ethics. 2013;14:55.
DOI
|
22 |
Franzel B, Schwiegershausen M, Heusser P, Berger B. Individualised medicine from the perspectives of patients using complementary therapies: a meta-ethnography approach. BMC Complement Altern Med. 2013;13:124.
DOI
|
23 |
Straus SE, McAlister FA. Evidence-based medicine: a commentary on common criticisms. CMAJ. 2000 Oct 3;163(7):837-41.
|
24 |
Tonelli MR. The philosophical limits of evidence-based medicine. Acad Med. 1998; 73(12):1234-40.
DOI
|
25 |
Goldman JJ, Shih TL. The limitations of evidence-based medicine--applying population-based recommendations to individual patients. Virtual Mentor. 2011;13(1):26-30.
DOI
|
26 |
Jain KK. Textbook of Personalized Medicine. New York:Springer. 2009:1-136.
|
27 |
Cohen AM, Stavri PZ, Hersh WR. A categorization and analysis of the criticisms of Evidence-Based Medicine. Int J Med Inform. 2004;73(1):35-43.
DOI
|
28 |
Ginsburg GS, McCarthy JJ. Personalized medicine: revolutionizing drug discovery and patient care. Trends Biotechnol. 2001;19(12): 491-6.
DOI
ScienceOn
|
29 |
Ray O. The revolutionary health science of psychoendoneuroimmunology: a new paradigm for understanding health and treating illness. Ann N Y Acad Sci. 2004;1032:35-51.
DOI
|
30 |
Yan Q. Toward the integration of personalized and systems medicine: challenges, opportunities and approaches. Personalized Medicine. 2011; 8(1):1-4.
DOI
|
31 |
Frueh FW, Amur S, Mummaneni P, Epstein RS, Aubert RE, DeLuca TM, et al. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use. Pharmacotherapy. 2008;28(8):992-8.
DOI
ScienceOn
|
32 |
Novelli G. Personalized genomic medicine. Intern Emerg Med. 2010;5(1):81-90.
|
33 |
Lee SW, Lee KB, Kang JW, Choi JH, Oh JH. Trends in Personalized Medicine Research, Communications of the Korean Institute of Information Scientists and Engineer. 2011;29(4): 19-25.
|
34 |
Emilien G, Ponchon M, Caldas C, Isacson O, Maloteaux JM. Impact of genomics on drug discovery and clinical medicine. QJM. 2000; 93(7):391-423.
DOI
|